DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantis Investment Advisers L.P. | 15,200 | $3,377,000 | 2.51% |
| Moreno Evelyn V | 45,410 | $10,087,000 | 2.51% |
| NBW CAPITAL LLC | 37,009 | $8,221,000 | 2.50% |
| QP WEALTH MANAGEMENT, LLC | 10,173 | $2,260,000 | 2.49% |
| Akre Capital Management | 1,655,300 | $367,708,000 | 2.48% |
| NIXON PEABODY TRUST CO | 26,111 | $5,800,000 | 2.45% |
| BRASADA CAPITAL MANAGEMENT, LP | 47,863 | $10,632,000 | 2.43% |
| Knowledge Leaders Capital, LLC | 12,502 | $2,777,000 | 2.41% |
| DAVIS R M INC | 378,609 | $84,104,000 | 2.41% |
| DILLON & ASSOCIATES INC | 50,059 | $11,113,000 | 2.41% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 181,418 | $40,301,000 | 2.40% |
| Main Street Research LLC | 100,419 | $22,307,000 | 2.40% |
| Private Wealth Partners, LLC | 99,310 | $22,061,000 | 2.39% |
| CARDEROCK CAPITAL MANAGEMENT INC | 35,668 | $7,923,000 | 2.39% |
| FIRST MANHATTAN CO. LLC. | 2,240,199 | $497,638,000 | 2.38% |
| HEADINVEST, LLC | 50,113 | $11,132,000 | 2.36% |
| Broadleaf Partners, LLC | 26,859 | $5,966,000 | 2.36% |
| Bank Pictet & Cie (Europe) AG | 214,247 | $47,593,000 | 2.34% |
| GARRISON POINT ADVISORS, LLC | 12,967 | $2,880,000 | 2.32% |
| EPIQ PARTNERS, LLC | 14,934 | $3,317,000 | 2.31% |
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DANAHER CORPORATION's shareholders in Q4 2020. To view DANAHER CORPORATION's shareholder history, click here.